{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spondyloarthropathies&page=2", "query": { "condition": "Spondyloarthropathies", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Spondyloarthropathies&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T13:13:38.845Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06864026", "title": "A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriatic Arthritis", "Overweight or Obesity" ], "interventions": [ { "name": "Tirzepatide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 200, "start_date": "2025-03-06", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-06-11", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 53, "location_summary": "Avondale, Arizona • Chandler, Arizona • Flagstaff, Arizona + 48 more", "locations": [ { "city": "Avondale", "state": "Arizona" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Flagstaff", "state": "Arizona" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Glendale", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT06864026" }, { "nct_id": "NCT02969525", "title": "A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Placebo", "type": "OTHER" }, { "name": "Bimekizumab", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "UCB Biopharma S.P.R.L.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 206, "start_date": "2016-10", "completion_date": "2018-07", "has_results": true, "last_update_posted_date": "2023-03-20", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 13, "location_summary": "San Diego, California • Aventura, Florida • Hagerstown, Maryland + 10 more", "locations": [ { "city": "San Diego", "state": "California" }, { "city": "Aventura", "state": "Florida" }, { "city": "Hagerstown", "state": "Maryland" }, { "city": "Lansing", "state": "Minnesota" }, { "city": "Lexington", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT02969525" }, { "nct_id": "NCT04751396", "title": "Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Ankylosing Spondylitis", "Autoimmune Disease", "Crohn Disease", "Enteropathic Arthritis", "Enteropathic Spondylitis", "Inflammatory Bowel Disease", "Melanoma", "Psoriasis", "Psoriatic Arthritis", "Reactive Arthritis", "Rheumatoid Arthritis", "Systemic Lupus Erythematosus", "Ulcerative Colitis" ], "interventions": [ { "name": "Best Practice", "type": "OTHER" }, { "name": "Educational Intervention", "type": "OTHER" }, { "name": "Interview", "type": "OTHER" }, { "name": "Questionnaire Administration", "type": "OTHER" }, { "name": "Survey Administration", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 125, "start_date": "2022-04-20", "completion_date": "2027-02-02", "has_results": false, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT04751396" }, { "nct_id": "NCT00000416", "title": "Prevention of Arthritis-Related Work Disability", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Rheumatoid Arthritis", "Systemic Lupus Erythematosus", "Osteoarthritis, Knee", "Ankylosing Spondylitis" ], "interventions": [ { "name": "Rehabilitation counseling", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "Boston University Charles River Campus", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 242, "start_date": "1997-09", "completion_date": "2001-08", "has_results": false, "last_update_posted_date": "2017-07-26", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000416" }, { "nct_id": "NCT03104400", "title": "A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Adalimumab", "type": "DRUG" }, { "name": "Upadacitinib", "type": "DRUG" }, { "name": "Placebo to Upadacitinib", "type": "DRUG" }, { "name": "Placebo to Adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1705, "start_date": "2017-04-27", "completion_date": "2024-09-09", "has_results": true, "last_update_posted_date": "2025-09-22", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 114, "location_summary": "Huntsville, Alabama • Peoria, Arizona • Phoenix, Arizona + 100 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03104400" }, { "nct_id": "NCT01199809", "title": "A Study of RO5310074 in Patients With Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Arthritis, Psoriatic" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "RO5310074", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 19, "start_date": "2011-02", "completion_date": "2012-02", "has_results": false, "last_update_posted_date": "2016-10-27", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 6, "location_summary": "Anniston, Alabama • Los Angeles, California • Miami, Florida + 3 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Miami", "state": "Florida" }, { "city": "Duncansville", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01199809" }, { "nct_id": "NCT02019602", "title": "A Multicener, Postmarketing Study Evaluating the Transfer of Cimzia From the Mother to the Infant Via the Placenta", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Axial Spondyloarthritis (AxSpA)", "Non-radiographic Evidence-AxSpA", "Ankylosing Spondylitis", "Crohn's Disease", "Psoriatic Arthritis", "Rheumatoid Arthritis" ], "interventions": [ { "name": "Blood sampling from mother", "type": "PROCEDURE" }, { "name": "Blood sampling from infant", "type": "PROCEDURE" }, { "name": "Blood sampling from umbilical cord", "type": "PROCEDURE" }, { "name": "Certolizumab Pegol", "type": "BIOLOGICAL" } ], "intervention_types": [ "PROCEDURE", "BIOLOGICAL" ], "sponsor": "UCB BIOSCIENCES, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 37, "start_date": "2014-01", "completion_date": "2016-11", "has_results": true, "last_update_posted_date": "2019-06-21", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 3, "location_summary": "Scottsdale, Arizona • Oklahoma City, Oklahoma • Salt Lake City, Utah", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Oklahoma City", "state": "Oklahoma" }, { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT02019602" }, { "nct_id": "NCT02696798", "title": "A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spondyloarthritis" ], "interventions": [ { "name": "Ixekizumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 316, "start_date": "2016-04-12", "completion_date": "2019-05-03", "has_results": true, "last_update_posted_date": "2020-06-17", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 27, "location_summary": "Phoenix, Arizona • Escondido, California • Huntington Beach, California + 24 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Escondido", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02696798" }, { "nct_id": "NCT03552276", "title": "Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "SUNPG18_07 I (Tildrakizumab 200 mg)", "type": "DRUG" }, { "name": "SUNPG18_07 II (Tildrakizumab 100 mg)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sun Pharmaceutical Industries Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 281, "start_date": "2018-07-11", "completion_date": "2023-09-18", "has_results": true, "last_update_posted_date": "2024-11-21", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 13, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Denver, Colorado + 10 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Denver", "state": "Colorado" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT03552276" }, { "nct_id": "NCT01583374", "title": "Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondyloarthritis" ], "interventions": [ { "name": "Apremilast tablet 20 mg", "type": "DRUG" }, { "name": "Apremilast tablet 30 mg BID", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 490, "start_date": "2012-05-02", "completion_date": "2018-10-25", "has_results": true, "last_update_posted_date": "2020-05-12", "last_synced_at": "2026-07-24T13:13:38.845Z", "location_count": 20, "location_summary": "Peoria, Arizona • La Jolla, California • Palm Desert, California + 17 more", "locations": [ { "city": "Peoria", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Pinellas Park", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01583374" } ] }